Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Positive Investors Forum 2019: Daring sustainable transformation

On Thursday 4 July, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, will join a panel discussion at the Positive Investors Forum 2019.

Date

04 July 2019

Organised by Novethic, the Positive Investors Forum connects investors, corporate executives and experts to foster strategies that generate a positive impact on society and the environment. The theme of this year’s Forum is ‘Daring Sustainable Transformation’.

Jayasree Iyer will take part in a panel discussion titled ‘Changing the conversation with investors’, together with Kathleen Tregoning, Executive Vice President, External Affairs at Sanofi (view Sanofi's performance in the 2018 Access to Medicine Index). Anne-Catherine Husson-Traore, CEO of Novethic will chair the discussion.  

Access to medicine is increasingly being seen as a material ESG issue for the pharmaceutical industry, and a growing number of investors are seeking for companies to demonstrate effective management of such ESG factors. In this panel discussion, Jayasree K. Iyer will share insights into how investors use the Access to Medicine Index in their investment strategies. 

91 institutional investors collectively managing assets of $12 trillion, have already committed to using the Access to Medicine Index in their investment analyses and engagements with companies, by signing the Index investor statement. The Sustainability Accounting Standard Board (SASB) also makes explicit reference to the framework of the Access to Medicine Index in the recently published SASB Standard for the Biotechnology & Pharmaceuticals industry. 

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved